Coltac Therapeutics

About

Funding history · 2 rounds · $5.0M total

Q&A

What is Coltac Therapeutics' primary focus?

Coltac Therapeutics is a preclinical pharmaceutical company developing a bacteria-based synthetic positive selection screening system for discovering molecular glues.

When was Coltac Therapeutics founded?

Coltac Therapeutics was founded in January 2022.

How many employees does Coltac Therapeutics have?

Coltac Therapeutics has 1-10 employees.

What is the total amount of funding Coltac Therapeutics has raised to date?

Coltac Therapeutics has raised a total of $5,000,000 USD.

When was Coltac Therapeutics' most recent funding round and who were the lead investors?

Coltac Therapeutics' most recent funding round was in September 2024, with aMoon Fund as a lead investor.

What is Coltac Therapeutics' current funding stage?

Coltac Therapeutics is currently in the Seed funding stage.

In which sector does Coltac Therapeutics primarily operate?

Coltac Therapeutics operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.

Where is Coltac Therapeutics headquartered?

Coltac Therapeutics is headquartered in Ra'anana, Israel.

Sectors & technology

Tags